John Hooper retweeted
Happy to have our review out in @CR_AACR on what some would call THE BEST receptor: CDCP1. Inquire within. @MaterResearch @TRI_info @ProfJohnHooper @TomaKryza @Nichola17676565
cancerres.aacrjournals.org/c…
John Hooper retweeted
Today begins a new era for ovarian cancer research. Professor John Hooper and team have secured four Federal Government Medical Research Future Fund grants for the next phase in #clinicaltesting.
Find out more➡️ mater.li/next-stage
@MaterNews @TRI_info @CSIRO @UQ_News
John Hooper retweeted
CEO Michelle Stewart highlighting the need to invest in research on @abc730 tonight....
#Pancreatic #cancer will soon overtake breast cancer in fatalities in Australia. It's difficult to diagnose and 9 out of 10 patients die within five years. Now there's a push to give it more attention and vital research funding. #abc730 @ashmcghee
John Hooper retweeted
Interview with @AvnerFoundation 2019 #Innovation Grant recipient Prof. John Hooper from @UQ_News discussing the development of new precision-medicine agents for detection & treatment #pancreaticcancer #cancerresearch #cancerofourgeneration @UQscience
John Hooper retweeted
Our lab’s brainchild is out! In this paper, we show inhibition of endocytosis is able to trap drug targets on cancer cell surfaces, which monoclonal antibodies can bind to, thus allowing immune cells to recognise and kill cancer cells. @PARFoundation @UQMedicine @TRI_info – at Brisbane, Queensland
Article in this issue of Cell: Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies - zpr.io/tF6LY
John Hooper retweeted
Today, 8 May, is #WorldOvarianCancerDay.
Meet Mater researcher Professor John Hooper who is working with his team based at @TRI_info on finding a cure for Ovarian Cancer.
You can find out more about his research here: mater.li/OCR
John Hooper retweeted
This is great news! Congratulations to @ProfJohnHooper #OvarianCancer
This Post is from an account that no longer exists. Learn more










